Ausgabe 3/2018
Inhalt (10 Artikel)
Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?
Roy O. Mathew, Elvira O. Gosmanova, Mandeep S. Sidhu
Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway
Angshuman Maulik, Sean M. Davidson, Izabela Piotrowska, Malcolm Walker, Derek M. Yellon
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study)
Marian Goicoechea, Soledad García de Vinuesa, Borja Quiroga, Eduardo Verde, Carmen Bernis, Enrique Morales, Gema Fernández-Juárez, Patricia de Sequera, Ursula Verdalles, Ramón Delgado, Alberto Torres, David Arroyo, Soraya Abad, Alberto Ortiz, José Luño
A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data
Richard Ofori-Asenso, Jenni Ilomäki, Ella Zomer, Andrea J. Curtis, Sophia Zoungas, Danny Liew
Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions
Susan H. Boklage, Elisabetta Malangone-Monaco, Lorena Lopez-Gonzalez, Yao Ding, Caroline Henriques, Joseph Elassal
Target Population of Non-deferrable Surgery and Uncontrolled Severe Bleeding Related to Dabigatran
Silvia Calabria, Emanuele Forcesi, Letizia Dondi, Antonella Pedrini, Aldo Pietro Maggioni, Nello Martini
Ticagrelor Versus Clopidogrel as Part of Dual or Triple Antithrombotic Therapy: a Systematic Review and Meta-Analysis
Ioannis Andreou, Alexandros Briasoulis, Christos Pappas, Ignatios Ikonomidis, Dimitrios Alexopoulos
Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial
Xianliang Wang, Zhiqiang Zhao, Yazhu Hou, E. Tang, Guoyuan Zhao, Shuai Wang, Yingfei Bi, Chengliang Zhong, Ming Ren, Junhua Zhang, Jingyuan Mao, Boli Zhang
Systematic Review of Methods Used for the Microvascular Assessment of Peripheral Arterial Disease
Qinzhong Chen, Robert S. Rosenson
Effect of Anagliptin and Sitagliptin in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: What Is the Real REASON Behind It?
Venu Gopal Jonnalagadda, Harish Prabhanna Char, Praveen Kumar Ankana